Benefits of DIM (Diindolylmethane)

Evidence-Based Benefits

• Estrogen metabolism modulation — Dalessandri et al. (2004) demonstrated that DIM supplementation significantly increased the urinary 2:16α-OHE1 ratio in postmenopausal women with a history of breast cancer, indicating a shift toward less proliferative estrogen metabolites
• Hormonal balance — by promoting the 2-hydroxylation pathway, DIM may help reduce symptoms associated with relative estrogen excess, including PMS, fibrocystic breast changes, and hormonal acne
• Anti-proliferative potential — in vitro studies consistently show DIM inhibits cell proliferation in estrogen-sensitive cell lines, though clinical translation is still being studied
• Cruciferous vegetable benefits — DIM provides the estrogen-modulating benefits associated with high cruciferous vegetable intake in a concentrated supplement form

What the Research Says

DIM research has focused on its ability to modulate estrogen metabolism, particularly the 2:16α-OHE1 ratio. Dalessandri et al. (2004) conducted a dose-finding study in postmenopausal women with early-stage breast cancer history, finding that 108mg of enhanced-absorption DIM (BioResponse) daily significantly increased the urinary 2:16α-OHE1 ratio. Thomson et al. (2017) confirmed these findings in a larger trial. The preferential shift toward 2-hydroxylation is considered potentially protective because 2-OHE1 has weak estrogenic activity and may have anti-proliferative properties, while 16α-OHE1 is a potent estrogen metabolite. In vitro and animal studies support anti-cancer mechanisms, but large-scale clinical cancer prevention trials are still needed.

Related Conditions